Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines
Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice and assessed by 31 independent reviewers.
